LeMaitre Vascular VP receives dividend rights

LeMaitre Vascular’s Senior Vice President of Operations received small dividend-equivalent right accruals linked to prior RSU and PSU equity awards.

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC (symbol: LMAT) is the issuer of record for a Form 4 filing submitted to the SEC. Kamke Trent G reported acquisition or exercise transactions in this Form 4 filing.

LEMAITRE VASCULAR INC (LMAT) reported that Senior V. P., Operations, Trent G. Kamke received multiple dividend equivalent rights awards on September 3, 2026. The awards, in small fractional amounts tied to prior restricted stock unit and performance share unit grants, are each the economic equivalent of one share of common stock and vest proportionately with the underlying awards. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 13.8555 shares

Grant/Award 7 txns

Insider Kamke Trent G

Role Senior V. P., Operations

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	0.9556	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F2	0.9556	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F3	1.6351	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F4	1.9599	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F5	2.1927	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F6	2.4831	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights F7	3.6735	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 85.4472 contracts (Direct)

Footnotes (7)

1. F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
2. F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
3. F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
4. F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
5. F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
6. F6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
7. F7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Dividend equivalent rights granted (F1-linked RSU award): 0.9556 rights Dividend equivalent rights granted (F2-linked PSU award): 0.9556 rights Dividend equivalent rights granted (F3-linked RSU award): 1.6351 rights +4 more

7 metrics

Dividend equivalent rights granted (F1-linked RSU award) 0.9556 rights Accrued on a restricted stock unit award granted on December 12, 2022; each right equals one common share economically

Dividend equivalent rights granted (F2-linked PSU award) 0.9556 rights Accrued on a performance share unit award granted on December 12, 2022; each right equals one common share economically

Dividend equivalent rights granted (F3-linked RSU award) 1.6351 rights Accrued on a restricted stock unit award granted on December 8, 2023; each right equals one common share economically

Dividend equivalent rights granted (F4-linked PSU award) 1.9599 rights Accrued on a performance share unit award granted on December 8, 2023; each right equals one common share economically

Dividend equivalent rights granted (F5-linked RSU award) 2.1927 rights Accrued on a restricted stock unit award granted on December 6, 2024; each right equals one common share economically

Dividend equivalent rights granted (F6-linked PSU award) 2.4831 rights Accrued on a performance share unit award granted on December 6, 2024; each right equals one common share economically

Dividend equivalent rights granted (F7-linked RSU award) 3.6735 rights Accrued on a restricted stock unit award granted on December 10, 2025; each right equals one common share economically

Key Terms

Dividend Equivalent Rights, restricted stock unit award, performance share unit award, economic equivalent of one share

4 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award granted"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit award financial

"These dividend equivalent rights accrued on a restricted stock unit award granted"

A restricted stock unit award is a promise by a company to give an employee a specified number of company shares at a future date if certain conditions are met, such as staying with the company or hitting performance goals. For investors, these awards matter because they can increase the total number of shares outstanding when converted, diluting existing holders, and they align employees’ incentives with shareholders’ interests much like giving a rising bonus that becomes real only after conditions are satisfied.

performance share unit award financial

"These dividend equivalent rights accrued on a performance share unit award granted"

economic equivalent of one share financial

"Each dividend equivalent right is the economic equivalent of one share"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LMAT report for Trent G. Kamke on September 3, 2026?

LMAT reported that Senior V. P., Operations, Trent G. Kamke received multiple dividend equivalent rights awards on September 3, 2026. These are derivative awards that mirror dividends on prior RSU and PSU equity grants and are the economic equivalent of common shares.

What are the dividend equivalent rights reported for LMAT on this Form 4?

The filing describes dividend equivalent rights that accrued on existing restricted stock unit and performance share unit awards. Each dividend equivalent right is stated to be the economic equivalent of one share of LeMaitre Vascular common stock and vests proportionately with the related award.

How many separate dividend equivalent rights transactions were reported for LMAT’s officer?

Seven separate acquisitions of dividend equivalent rights were reported, all dated September 3, 2026. Each transaction relates to dividend accruals on different restricted stock unit or performance share unit awards granted between December 12, 2022 and December 10, 2025.

Do the LMAT dividend equivalent rights have an exercise price or cash purchase price?

No cash price is reported. Each transaction lists a per‑share price of $0.0000, and the footnotes describe the awards as dividend equivalent rights that accrue and vest with underlying RSU or PSU awards rather than being purchased in the market.

Are the LMAT insider’s dividend equivalent rights part of a Rule 10b5-1 trading plan?

The Form 4 indicates the document-level Rule 10b5-1 checkbox is not marked, and no footnote states that the transactions were made under a trading plan. The filing therefore does not report these awards as made pursuant to a Rule 10b5-1 plan.

What underlying awards do the LMAT dividend equivalent rights relate to?

Footnotes state the dividend equivalent rights accrued on restricted stock unit and performance share unit awards granted on December 12, 2022, December 8, 2023, December 6, 2024, and December 10, 2025. The rights vest proportionately with each respective underlying award.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:46 PM Accepted by SEC EDGAR 09/08/2026 - 04:45 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kamke Trent G

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR , INC.

63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior V. P., Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/03/2026		A		0.9556		(1)	(1)	Common Stock	0.9556	$0	11.2033	D
Dividend Equivalent Rights	(2)	09/03/2026		A		0.9556		(2)	(2)	Common Stock	0.9556	$0	11.1949	D
Dividend Equivalent Rights	(3)	09/03/2026		A		1.6351		(3)	(3)	Common Stock	1.6351	$0	13.5014	D
Dividend Equivalent Rights	(4)	09/03/2026		A		1.9599		(4)	(4)	Common Stock	1.9599	$0	14.774	D
Dividend Equivalent Rights	(5)	09/03/2026		A		2.1927		(5)	(5)	Common Stock	2.1927	$0	12.2651	D
Dividend Equivalent Rights	(6)	09/03/2026		A		2.4831		(6)	(6)	Common Stock	2.4831	$0	13.0157	D
Dividend Equivalent Rights	(7)	09/03/2026		A		3.6735		(7)	(7)	Common Stock	3.6735	$0	9.4928	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

6. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

7. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Douglas G. Bush, Attorney-in-fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)